Gimv - News

05/03/2020 - 10:46 Portfolio

Gimv beteiligt sich an AME, einem auf smarte Elektrotechnik spezialisierten Hersteller mit Sitz im Eindhovener Brainport

20/02/2020 - 17:50 Portfolio

Gimv geht Partnerschaft mit Firmengruppe Köberl für weiteres Wachstum im Gebäudetechnik- und Gebäudemanagement-Bereich ein

18/02/2020 - 11:44 Portfolio

IMPACT and Haldu Groep guarantee continuity for employees, temporary workers and customers through the acquisition of a number of standalone activities of DeGraaf Groep

06/02/2020 - 18:24 Portfolio

JenaValve Technology Closes USD 50 Million Financing

23/01/2020 - 11:39 Portfolio

General Fusion Closes $65M of Series E Financing - Gimv contributes to the search of an answer for a carbon-free energy future

19/12/2019 - 09:22 Portfolio

Topas Therapeutics Announces First Patient Enrolled in Phase 1 Trial with TPM203 in Pemphigus Vulgaris

12/12/2019 - 09:00 Portfolio

Cegeka reinforces international position by acquiring KPN Consulting

04/12/2019 - 06:45 Portfolio

ImCheck Therapeutics erhält 53 Millionen US-Dollar bei Serie-B-Runde – Gimv erhöht Investments im Bereich Immunonkologie

27/11/2019 - 10:27 Portfolio

Backed by Gimv, French Groupe Claire acquires Ijinus and reinforces its products pole for water systems equipment and solutions

21/11/2019 - 07:00 Finanziell

Halbjahresergebnisse: Weiteres Wachstum und anhaltend starke Portfolioergebnisse

29/10/2019 - 15:43 Portfolio

GTX medical BV and NeuroRecovery Technologies Inc. Merge to Create Leading Neurostimulation Company for Spinal Cord Injury

14/10/2019 - 08:00 Portfolio

Eric de Montgolfier appointed as CEO of Invest Europe

09/09/2019 - 16:50 Portfolio

One of A Kind Technologies expands with KOAT to accelerate Agriculture growth strategy

09/09/2019 - 13:46 Portfolio

Equipe Zorgbedrijven beabsichtigt die Heuvelrug Augenklinik zu übernehmen

05/09/2019 - 08:00 Portfolio

iSTAR Medical announces EUR 40.1 million financing round lead by Gimv to support further development of an innovative glaucoma treatment

30/07/2019 - 08:00 Portfolio

AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection.

30/07/2019 - 07:45 Portfolio

Gimv veräußert Anteil am Stuttgarter Spezialisten für Nachhaltigkeitssoftware thinkstep AG.

30/07/2019 - 07:30 Portfolio

Gimv exits Legallais, ironmongery distributor for building professionals in France.

25/07/2019 - 08:00 Portfolio

Nach besonders schneller Entwicklung: Gimv und Mitinvestoren veräußern Biopharmaunternehmen Breath Therapeutics an Zambon

26/06/2019 - 17:45 Finanziell

Report of the Annual General Shareholders’ Meeting - Approval of a gross dividend of EUR 2.50 per share

21/06/2019 - 17:45 Finanziell

Closure of the subscription periods for the bond issue for private and institutional investors for the total maximum amount of EUR 250 million

19/06/2019 - 07:30 Finanziell

Gimv NV launches a bond-issue for retail and institutional investors for a total nominal amount of at least EUR 150 million

Pressemitteilungen filtern:

Biotalys announces second closing Series C totaling €45m

Itineris is looking for 60 new employees to accelerate growth

Alro is nominated trendsgazelle ambassador for medium sized companies

Gimv beteiligt sich an AME, einem auf smarte Elektrotechnik spezialisierten Hersteller mit Sitz im Eindhovener Brainport

Gimv geht Partnerschaft mit Firmengruppe Köberl für weiteres Wachstum im Gebäudetechnik- und Gebäudemanagement-Bereich ein

IMPACT and Haldu Groep guarantee continuity for employees, temporary workers and customers through the acquisition of a number of standalone activities of DeGraaf Groep

JenaValve Technology Closes USD 50 Million Financing

General Fusion Closes $65M of Series E Financing - Gimv contributes to the search of an answer for a carbon-free energy future

Topas Therapeutics Announces First Patient Enrolled in Phase 1 Trial with TPM203 in Pemphigus Vulgaris

Cegeka reinforces international position by acquiring KPN Consulting

ImCheck Therapeutics erhält 53 Millionen US-Dollar bei Serie-B-Runde – Gimv erhöht Investments im Bereich Immunonkologie

Backed by Gimv, French Groupe Claire acquires Ijinus and reinforces its products pole for water systems equipment and solutions

Halbjahresergebnisse: Weiteres Wachstum und anhaltend starke Portfolioergebnisse

GTX medical BV and NeuroRecovery Technologies Inc. Merge to Create Leading Neurostimulation Company for Spinal Cord Injury

Eric de Montgolfier appointed as CEO of Invest Europe

One of A Kind Technologies expands with KOAT to accelerate Agriculture growth strategy

Equipe Zorgbedrijven beabsichtigt die Heuvelrug Augenklinik zu übernehmen

iSTAR Medical announces EUR 40.1 million financing round lead by Gimv to support further development of an innovative glaucoma treatment

AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection.

Gimv veräußert Anteil am Stuttgarter Spezialisten für Nachhaltigkeitssoftware thinkstep AG.

Gimv exits Legallais, ironmongery distributor for building professionals in France.

Nach besonders schneller Entwicklung: Gimv und Mitinvestoren veräußern Biopharmaunternehmen Breath Therapeutics an Zambon

Report of the Annual General Shareholders’ Meeting - Approval of a gross dividend of EUR 2.50 per share

Closure of the subscription periods for the bond issue for private and institutional investors for the total maximum amount of EUR 250 million

Gimv NV launches a bond-issue for retail and institutional investors for a total nominal amount of at least EUR 150 million